New Study Shows Effect of Neupro® (Rotigotine Transdermal System) on … – PR Newswire (press release)

by admin on May 17, 2013

New Study Shows Effect of Neupro® (Rotigotine Transdermal System) on
PR Newswire (press release)
Neupro® (Rotigotine Transdermal System) is indicated for the treatment of the signs and symptoms of idiopathic Parkinson's disease and moderate-to-severe primary Restless Legs Syndrome (RLS). For more information about Neupro visit www.neupro.com.

and more »

View full post on restless leg syndrome – Google News

Leave a Comment

Previous post:

Next post: